BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8396082)

  • 1. Clinical safety and tolerance of azithromycin in children.
    Hopkins S
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():111-7. PubMed ID: 8396082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
    Rodriguez-Solares A; Pérez-Gutiérrez F; Prosperi J; Milgram E; Martin A
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():103-9. PubMed ID: 8396081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children.
    Schaad UB
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():81-8. PubMed ID: 8396101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children.
    Daniel RR
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():65-71. PubMed ID: 8396099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children.
    Hamill J
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():89-94. PubMed ID: 8396102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric safety of azithromycin: worldwide experience.
    Treadway G; Pontani D
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():143-9. PubMed ID: 8818855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media.
    Mohs E; Rodriguez-Solares A; Rivas E; el Hoshy Z
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():73-9. PubMed ID: 8396100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci.
    Weippl G
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():95-101. PubMed ID: 8396103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical toleration and safety of azithromycin.
    Hopkins S
    Am J Med; 1991 Sep; 91(3A):40S-45S. PubMed ID: 1656742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
    Müller O
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():137-46. PubMed ID: 8396085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Felstead SJ; Daniel R
    J Int Med Res; 1991; 19(5):363-72. PubMed ID: 1660823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(6):433-45. PubMed ID: 1663466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily azithromycin in the treatment of adult skin and skin-structure infections.
    Amaya-Tapia G; Aguirre-Avalos G; Andrade-Villanueva J; Peredo-González G; Morfín-Otero R; Esparza-Ahumada S; Rodríguez-Noriega E
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():129-35. PubMed ID: 8396084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
    Casey JR; Pichichero ME
    Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.
    Khan WA; Saha D; Rahman A; Salam MA; Bogaerts J; Bennish ML
    Lancet; 2002 Nov; 360(9347):1722-7. PubMed ID: 12480424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.